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Abstract
The nucleophilic addition of 4-aminophenol 1 to 2-chloro-N, N-dimethyethylamine 2 generated
intermediate 3. Following oxidation facilitated by [bis(trifluoroacetoxy)iodo]benzene (PIFA, 4)
created quinoneimine 5. Then, Compound 5 went under nucleophilic Michael Addition with 3mercaptopropionic acid and subsequent cyclization with coupling reagent N,N'dicyclohexylcarbodiimide (DCC) 7, to generate the desired analogs of Diltiazem/Clentiazem 8.
This four-step total synthesis approach provides a high yielding novel synthesis methodology.

Scheme 1. General Synthesis of Analogs of Diltiazem/Clentiazem
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Introduction
In today’s society, cardiovascular diseases are rampant. According to the World Health
Organization, cardiovascular disease accounts for 30% of all global deaths1. Therefore,
researchers put a big effort into trying to find a drug that will cure these diseases. Drugs
containing a benzothiazepinone core structure are known to be potent in treating cardiovascular
diseases.2 Thus, researchers have synthesized benzothiazepinones such as Diltiazem and
Clentiazem and their analogs, Figure 1. A Chinese team synthesized benzothiazepinone
derivatives from 1,5-difluoro-2,4-dinitrobenzene.3 Whereas, a Japanese team synthesized
benzothiazepinone derivatives through fusion of the halogen-substituted 2-aminothiophenol with
the trans-3arylglycidic ester.4 Just like these scientists, the purpose of this research is to propose
a new synthetic route to benzothiazepinones that will have shorter reaction steps with cheaper
starting materials. To test the potency of the drug, the final product will be tested as a potential
vasodilator or calcium antagonist at a later determined time. By creating a shorter and more
affordable route to benzothiazepinone, we hope to impact society with a more effective
cardiovascular drug.

Figure 1. Diltiazem and Clentiazem structures
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Methods

Figure 2. Overall synthetic pathways of Diltiazem/Clentiazem analogs
The total synthesis of Diltiazem/Clentiazem analogs had two different pathways: Route 1
and Route 2 which are demonstrated in Figure 2. Bold numbers from the following passage and
figures refer to their corresponding compounds as it is listed in Figure 2. In Route 1,
nucleophilic addition of aniline 9, to 2-chloro-N,N-dimethyethylamine 2, successfully generated
dimethyl[2-(phenylamino)ethyl]amine 10. However, oxidation of compound 10 was
unsuccessful which led to the design of an alternative pathway. Therefore, in Route 2,
nucleophilic addition of 4-aminophenol 1, to 2-chloro-N, N-dimethyethylamine 2, generated
intermediate 3. This intermediate was oxidized by PIFA, followed by nucleophilic Michael
addition of 3-mercaptopropionic acid 6. Lastly, cyclization with DCC 7 generated the
Diltiazem/Clentiazem analogs 8.
Nucleophilic addition of 4-aminophenol to 2-chloro-N, N-dimethyethylamine5
In the nucleophilic addition, 12 mL of acetonitrile (ACN) was added to 0.5 mmol of
potassium iodide (KI). Then, 5 mmol of potassium carbonate (K2CO3), and 15 mmol of 4-
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aminophenol 1 were added respectively to the solution. Lastly, 5 mmol of 2-chloro-N, Ndimethyethylamine 2 were added to the mixture, and the reaction was left heating for 7 days at
110C. Then, the mixture was purified through flash column chromatography using ethyl acetate:
methanol: and ammonia (85:15:0.1) as a solvent system. The resulting product was dried in
vacuo and (4-{[2-(dimethylamino)ethyl]amino}phenol), compound 3, was formed.
Oxidation of (4-{[2-(dimethylamino)ethyl]amino}phenol)6
In the oxidation step, 0.227 mmol of the compound 3 was dissolved into
acetonitrile:water (2:1, 0.680mL). Then, 0.227 mmol of PIFA 4 was added to the solution. The
reaction vial was covered in aluminum foil and left stirring in room temperature for a week. This
reaction produced in situ 4-{[2-(dimethylamino)ethyl]imino}cyclohexa-2,5-dien-1-one 5. The
reaction mixture was used onto the next step without further purification and monitored by thin
layer chromatography (TLC). Once TLC detected a new spot and the starting material was
consumed, the solvent was dried in vacuo and stored to be used onto the following step.
Michael addition of 3-mercaptopropionic acid7
To a solution of 0.227 mmol of oxidized compound dissolved in 1.89 mL of ethanol
(EtOH), a solution of 0.227 mmol of 3-mercaptopropionic acid was added and the mixture was
stirred at room temperature for two days. Like the previous reaction, the addition of 3mercaptopropionic acid was monitored through TLC. This reaction produced 3-[(2-{[2(dimethylamino)ethyl]amino}-5-hydroxyphenyl)sulfanyl]propanoic acid, compound 6a, which
was evaporated in vacuo as well.
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Cyclization of 3-[(2-{[2-(dimethylamino)ethyl]amino}-5-hydroxyphenyl)sulfanyl]propanoic
acid7
A solution of 0.227 mmol of compound 6a was dissolved into 1 mL of tetrahydrofuran
(THF). Then, 0.227 mmol of DCC 7 was added to the solution. The solution was left stirring at
room temperature for four days. On the fourth day, TLC detected the presence of a new spot, so
flash column chromatography was performed. The eluent solvent system was ethyl acetate:
methanol: and ammonia (85:15:0.1). The compound was isolated and the solvent was evaporated
in vacuo. This reaction should have produced 5-[2-(dimethylamino)ethyl]-8-hydroxy-2,3,4,5tetrahydro-1,5-benzothiazepin-4-one 8, which is a Diltiazem/Clentiazem analog. Data analysis
of this step is in progress.
Results and Discussion
Nucleophilic addition of 4-aminophenol to of 2-chloro-N, N-dimethyethylamine
This reaction was run in two different ways: a front-run and a large scale. The front-run
produced 0.316g, 1.75 mmol, 35% yield. Whereas, the large scale yielded 3.500g, 18.6 mmol,
93% yield. The yield in the large scale run improved greatly due to having more material to work
with and an increase in technical knowledge and laboratory ability. The same purification
procedure was conducted for the column chromatography of both runs. Furthermore, both runs
isolated desired products and were analyzed by Dr. Herman H. Odens, the lead researcher, with
the courtesy of University of Tennessee at Chattanooga. Samples were analyzed by 1H and 13C
NMR using a Jeol 400MHz NMR. The 1H NMR spectrum of the front-run is illustrated in
Figure 3. Likewise, the large scale reaction 1H NMR spectrum is illustrated in Figure 4.
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Figure 3. 1H NMR of the front-run of compound 3
1

H NMR of the front-run and of the large scale are just as anticipated. All the expected

peaks are present and very few impurities are shown. Thus, the nucleophilic addition reaction
was conducted successfully. However, from the oxidation step onward, the researchers carried
out the total synthesis with no purification. Therefore, the results for the final synthesis of
Diltiazem and Clentiazem analogs are still in progress.
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Figure 4. H1 NMR of DSJC7-23 from large scale

In the nucleophilic step, there was a possibility of O-alkylation instead of N-alkylation.
However, both TLC and 1H NMR revealed that no such alkylation occurred. In fact, NMR
showed no trace of O-alkylation. This trend is consistent with common nucleophilicity
knowledge. Nitrogen is less electronegative and a better base than the oxygen atom, which
makes N-alkylation much more likely to happen.
This successful SN2 reaction is masked by the failure of Route 1, Figure 2, synthesis. As
in Route 2 nucleophilic reaction, the Route 1 nucleophilic reaction was fundamentally
successful and produced N1-ethyl-N2,N2-dimethyl-N1-phenyl-1,2-ethanediamine, 11 . However,
the insertion of a hydroxyl group to this molecule was unsuccessful. The TLC revealed a
8

breakdown of product and 1H NMR showed too many peaks to have any meaningful
interpretation. Thus, realizing the difficulty of inserting a hydroxyl group to N1-ethyl-N2,N2dimethyl-N1-phenyl-1,2-ethanediamine 11, the same reaction conditions were used in Route 2
with 4-aminophenol instead of aniline. This strategy not only gave a better result but also cut
down on total synthetic steps.
In the second step of Route 2, the oxidation of (4-{[2(dimethylamino)ethyl]amino}phenol)
compound 3 had several problems. The compound is heat and light sensitive, and also breaks
down in silica gel. Thus, no purification was done from this oxidation step onward because flash
column chromatography requires silica gel. Because of these sensitivities, four different
oxidizing agents were tried to find the best one, Figure 5. According to TLC, treatment of
compound 3 with PIFA 4 was the only reaction that successfully oxidized the (4-{[2(dimethylamino)ethyl]amino}phenol) 3. However, an attempt to isolate compound 5 by column
chromatography was unsuccessful.

Figure 5. Explosion chart of various oxidizing agents
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The oxidation steps show that redox reactions are usually substrate specific and not all
oxidants can oxidize the same molecule. Compound 3 seems to favor PIFA 4 over the others.
When Ag2O, KMnO4, and NaIO4 were used as oxidants, TLC showed many spots which are an
indication of multiple product formation. Possible causes for this would be over oxidation and
degradation of compounds, which was evident from TLC data of these three reactions. However,
exact reason why compound 3 favors PIFA is unclear.
Conclusion:
Although the research was slow in the beginning, a new methodology, Route 2, has been
successfully developed for the synthesis of Diltiazem/Clentiazem analogs. In the future, addition
of chiral groups to the 7-member ring of 5-[2-(dimethylamino)ethyl]-8-hydroxy-2,3,4,5tetrahydro-1,5-benzothiazepin-4-one 8 can be tested to understand how chirality and different
functional groups affect the biological activity. Lastly, Route 2 seems to be a viable procedure
for the synthesis of Diltiazem or Clentiazem analogs because the starting materials and reagents
used are relatively inexpensive and the procedure is mild.
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